《大行報告》瑞信:申洲(02313.HK)嚴控銷售成本支出 中期業績符預期
瑞信發表研究報告,指出申洲國際(02313.HK)中期業績符合預期,收入按年下跌0.4%至102.34億元人民幣,符合預期。純利按年上升0.4%至25.12億元人民幣。中期派息維持每股0.9元不變。整體毛利率穩定在30.9%。營運利潤率擴大至27.7%,主要是因為嚴格節省銷售及分銷成本所致。
公司在業績簡報中提到,消費者需求受到疫情影響只是階段性現象,而市場需求最終將迎來反彈。企業必須考慮成本增加的問題,及提高其應對轉變的能力。該行期望能在分析員會議中得到更多有關下半年需求及訂單前景的細節。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.